Late Conversion From Calcineurin Inhibitors to Belatacept in Kidney-Transplant Recipients Has a Significant Beneficial Impact on Glycemic Parameters

BACKGROUND. Calcineurin inhibitors (CNIs) and steroids are strongly associated with new-onset diabetes after transplantation, worsening of pre-existing diabetes, and cardiovascular events. We assessed the benefit of conversion from CNI-based to belatacept-based immunosuppression in diabetic kidney-t...

Descripción completa

Detalles Bibliográficos
Autores principales: Terrec, Florian, Jouve, Thomas, Naciri-Bennani, Hamza, Benhamou, Pierre-Yves, Malvezzi, Paolo, Janbon, Benedicte, Giovannini, Diane, Rostaing, Lionel, Noble, Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Kidney Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964931/
https://www.ncbi.nlm.nih.gov/pubmed/32047845
http://dx.doi.org/10.1097/TXD.0000000000000964

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964931/
https://www.ncbi.nlm.nih.gov/pubmed/32047845
http://dx.doi.org/10.1097/TXD.0000000000000964

Ejemplares similares